139 related articles for article (PubMed ID: 1844696)
1. Assessment of bioequivalence using a multiplicative model.
Chow SC; Peace KE; Shao J
J Biopharm Stat; 1991; 1(2):193-203. PubMed ID: 1844696
[TBL] [Abstract][Full Text] [Related]
2. Bioequivalence and intrasubject variability.
Liu JP
J Biopharm Stat; 1991; 1(2):205-19. PubMed ID: 1844697
[TBL] [Abstract][Full Text] [Related]
3. Average bioequivalence for two-sequence two-period crossover design with incomplete data.
Lee JY; Kim BC; Park SG
J Biopharm Stat; 2005; 15(5):857-67. PubMed ID: 16078389
[TBL] [Abstract][Full Text] [Related]
4. A new approach for outliers in a bioavailability/bioequivalence study.
Liao JJ
J Biopharm Stat; 2007; 17(3):393-405. PubMed ID: 17479389
[TBL] [Abstract][Full Text] [Related]
5. On assessment of bioequivalence under a higher-order crossover design.
Chow SC; Liu JP
J Biopharm Stat; 1992; 2(2):239-56. PubMed ID: 1300216
[TBL] [Abstract][Full Text] [Related]
6. Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar.
Schall R
Biometrics; 1995 Jun; 51(2):615-26. PubMed ID: 7662849
[TBL] [Abstract][Full Text] [Related]
7. Optimal sampling times in bioequivalence tests.
Kong FH; Gonin R
J Biopharm Stat; 2000 Feb; 10(1):31-44. PubMed ID: 10709799
[TBL] [Abstract][Full Text] [Related]
8. A three-step procedure for assessing bioequivalence in the general mixed model framework.
Vuorinen J; Turunen J
Stat Med; 1996 Dec; 15(24):2635-55. PubMed ID: 8981677
[TBL] [Abstract][Full Text] [Related]
9. Extension to the use of tolerance intervals for the assessment of individual bioequivalence.
Esinhart JD; Chinchilli VM
J Biopharm Stat; 1994 Mar; 4(1):39-52. PubMed ID: 8019583
[TBL] [Abstract][Full Text] [Related]
10. On TIER method for assessment of individual bioequivalence.
Ju HL
J Biopharm Stat; 1997 Mar; 7(1):63-85. PubMed ID: 9056589
[TBL] [Abstract][Full Text] [Related]
11. Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designs.
Quiroz J; Ting N; Wei GC; Burdick RK
Stat Med; 2002 Jul; 21(13):1825-47. PubMed ID: 12111892
[TBL] [Abstract][Full Text] [Related]
12. Statistical aspects of comparative bioavailability trials.
Westlake WJ
Biometrics; 1979 Mar; 35(1):273-80. PubMed ID: 583027
[TBL] [Abstract][Full Text] [Related]
13. A two one-sided tests procedure for assessment of individual bioequivalence.
Liu J; Chow SC
J Biopharm Stat; 1997 Mar; 7(1):49-61. PubMed ID: 9056588
[TBL] [Abstract][Full Text] [Related]
14. Bayesian modeling of multivariate average bioequivalence.
Ghosh P; Gönen M
Stat Med; 2008 Jun; 27(13):2402-19. PubMed ID: 18095275
[TBL] [Abstract][Full Text] [Related]
15. A method for the evaluation of individual bioequivalence.
Endrenyi L
Int J Clin Pharmacol Ther; 1994 Sep; 32(9):497-508. PubMed ID: 7820334
[TBL] [Abstract][Full Text] [Related]
16. Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives.
Endrenyi L; Tothfalusi L
Int J Clin Pharmacol Ther; 1997 Apr; 35(4):142-50. PubMed ID: 9112134
[TBL] [Abstract][Full Text] [Related]
17. Types of bioequivalence and related statistical considerations.
Hauck WW; Anderson S
Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):181-7. PubMed ID: 1592546
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
19. Sample size determination: extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43.
Diletti E; Hauschke D; Steinijans VW
Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S59-62. PubMed ID: 1601533
[TBL] [Abstract][Full Text] [Related]
20. The assessment of individual and population bioequivalence.
Chinchilli VM
J Biopharm Stat; 1996 Mar; 6(1):1-14. PubMed ID: 8838775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
